aXichem Files Patent Application for Phenylcapsaicin as Bio-Enhancer for Certain Substrates of Cytochrome Isoforms, Enzymes Involved in the Metabolism of Pharmaceuticals
aXichem AB (publ), that develops and markets natural analogue industrial compounds, has filed a patent application for its product, phenylcapsaicin, as a bio-enhancer for substrates of certain Cytochrome P450 Isoforms, involved in the metabolism of several common pharmaceuticals. Phenylcapsaicin has been tested as a bio-enhancer for Cytochrome P450 Isoforms together with several active substances. Significant positive results were shown with a specific substrate of Cytochrome P450 that, among others, regulate melatonin. Melatonin is the endogenous hormone produced by the pineal gland that